AI-Enhanced Quantitative IHC Analysis for Prognostic Stratification in Marginal Zone Lymphoma: Development of a Revised MZL-IPI Model.

Qingyang Zhang, Zeyu Deng, Wenzhe Yan, Hongkai Zhu, Zizhu Tian, Yi Jiang, Hongling Peng

Abstract read

In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qingyang ZhangDepartment of Hematology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Zeyu DengDepartment of Hematology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Wenzhe YanDepartment of Hematology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Hongkai ZhuDepartment of Hematology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Zizhu TianDepartment of Hematology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Yi JiangDepartment of Pathology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Hongling PengDepartment of Hematology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.

Funding

Key Research and Development Program of Hunan Province 2024JK2112National Natural Science Foundation of China 82070175Natural Science Foundation of Guangxi Zhuang Autonomous Region 2024JJA140129Natural Science Foundation of Hunan Province 2022JJ30830Natural Science Foundation of Hunan Province 2024JJ5498Scientific Research Project of Hunan Provincial Health Commission W20243217

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

artificial intelligenceimmunohistochemistry quantificationmarginal zone lymphomaprognostic biomarkersrevised MZL-IPI model

Identifiers

PMID42196822

DOI10.3390/diagnostics16101456

PMCPMC13205237

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.